In an interview with Bloomberg, GSK (GSK) CEO Emma Walmsley said the company has been anticipating tariffs on the industry and is “confident” the company can navigate through it, Ashleigh Furlong and Ruth David of Bloomberg reports. The U.S. makes up over half of its business and has been a priority for investments, Walmsley added, according to Bloomberg. Additionally, in the interview, Walmsley said the company is “excited” about the opportunity in China and does not believe there is a direct impact in terms of China-US relations.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- Trump plans to announce ‘major’ tariff on pharmaceutical imports, Reuters says
- GSK Pharma call volume above normal and directionally bullish
- GSK pushes UK government to give more access to health data, Bloomberg says
- RFK Jr. plans to cut 10,000 jobs in HHS, WSJ reports
- Pfizer Stock (PFE) Slips as U.S. Probes the Timing of Its COVID-19 Vaccine Results